FDA Committee Weighs Merits Of Novavax's COVID-19 Vaccine

Share this & earn $10
Published at : June 09, 2022
Subscribe
The FDA's advisory committee is meeting Tuesday to discuss the benefits and risks of Novavax's COVID-19 vaccine. FDA Committee Weighs Merits Of Novavax's COVID-19 Vaccine
Eyewitness News Morning